
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
1 Department of Nutrition, Harvard School of Public Health, Boston, MA; 2 Department of Epidemiology, Harvard School of Public Health, Boston, MA; 3 Department of Public Health and Preventive Medicine, Oregon Health & Science University School of Medicine, Portland, OR; 4 Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA; 5 Naval Health Research Center, San Diego California and 6 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Requests for reprints: Edward Giovannucci, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. Phone: 617-432-4648; Fax: 617-432-2345. E-mail: egiovann{at}hsph.havard.edu
Background: Vitamin D status is associated inversely with risk of colorectal cancer, but the association with adenoma risk is less clear. This meta-analysis examined the overall relationship between circulating (plasma or serum) 25-hydroxyvitamin D [25(OH)D], vitamin D intake (dietary, supplemental, or total), and colorectal adenoma incidence in published studies.
Methods: A meta-analysis composed of 17 epidemiologic studies [1 cross-sectional, 9 case-control, and 7 cohort or nested case-control studies; 7 on 25(OH)D and 12 on vitamin D intake] published before December 2007 was done to examine the association between circulating 25(OH)D, vitamin D intake, and colorectal adenomas. Summary Peto odds ratios (OR) were computed for overall and stratified analyses.
Results: Circulating 25(OH)D was inversely associated with risk of colorectal adenomas: the OR was 0.70 [95% confidence interval (95% CI), 0.56-0.87] for high versus low circulating 25(OH)D. The highest quintile of vitamin D intake was associated with an 11% marginally decreased risk of colorectal adenomas compared with low vitamin D intake (OR, 0.89; 95% CI, 0.78-1.02). For recurrent adenomas, there was a decreased risk of 12% (95% CI, 0.72-1.07) among individuals with high versus low vitamin D intake. The inverse associations appeared stronger for advanced adenoma [OR, 0.64; 95% CI, 0.45-0.90 for serum 25(OH)D and OR, 0.77; 95% CI, 0.63-0.95 for vitamin D intake], but the number of studies was small.
Conclusions: Both circulating 25(OH)D and vitamin D intake were inversely associated with colorectal adenoma incidence and recurrent adenomas. These results further support a role of vitamin D in prevention of colorectal adenoma incidence and recurrence. (Cancer Epidemiol Biomarkers Prev 2008;17(11):2958–69)
This article has been cited by other articles:
![]() |
C. S. Zipitis Is Vitamin D Protective Against Development of Type 1 Diabetes Mellitus? ICAN: Infant, Child, & Adolescent Nutrition, April 1, 2009; 1(2): 108 - 112. [Abstract] [PDF] |
||||
![]() |
E. T. Jacobs, P. W. Jurutka, M. E. Martinez,, and D. S. Alberts Vitamin D, Calcium, and Colorectal Neoplasia: New Insights on Mechanisms of Action Cancer Prevention Research, March 1, 2009; 2(3): 197 - 199. [Full Text] [PDF] |
||||
![]() |
G. C. Prendergast Social and Physical Environments in Cancer Cancer Reviews Online Content, January 1, 2008; 2008(12): 23 - 23. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |